ALLi-TRIPLE 50 MG / 25 MG / 50 MG / 50 MG – 10 TABLETS
Active ingredients: Diclofenac 50 mg / Paracetamol 500 mg / Caffeine 50 mg / Chlorphenamine 4 mg
Concentration: 50 mg / 500 mg / 50 mg / 4 mg per tablet
Presentation: Box with 10 tablets
Laboratory: GENOMMA
Origin: Made in Mexico
What is it for?
ALLi-TRIPLE is a medication indicated for the relief of pain and general discomfort associated with inflammatory processes or flu symptoms.
Its combination of analgesic, anti-inflammatory, antihistamine and stimulant helps reduce pain, fever, congestion and other related symptoms.
How to Use
The dose should be indicated by the physician or according to the package instructions. Do not exceed the recommended dose or combine with other products containing paracetamol.
Warnings
-
Do not self-medicate.
-
May cause drowsiness.
-
Avoid alcohol consumption during treatment.
-
Do not use if allergic to any of the ingredients in the formula.
-
Keep out of reach of children.
The consumption of this product is the responsibility of those who recommend it and those who use it. Consult your doctor before taking any medication.

{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>